RHB Capital analyst Shekhar Jaiswal maintained a Buy rating on Raffles Medical Group (RAFLF – Research Report) today and set a price target of S$1.75. The company’s shares closed last Monday at $1.08.
According to TipRanks, Jaiswal is ranked #4440 out of 8331 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Raffles Medical Group with a $1.31 average price target.
See Insiders’ Hot Stocks on TipRanks >>
RAFLF market cap is currently $2.07B and has a P/E ratio of 19.64.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Raffles Medical Group Ltd. is an investment holding company, which engages in the operation of medical clinics and other general medical services. It operates through the following segments: Healthcare Services, Hospital Services, and Investment Holdings. The Healthcare Services segment includes the management of medical clinics and other general medical services, provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital Services segment provides specialized medical services and operates hospital and business of medical laboratory and imaging center. The Investment Holdings segment refers to the investment properties. The company was founded by Choon Yong Loo and Alfred Loh in 1976 and is headquartered in Singapore.
